ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
52 Percent Of Newly Diagnosed Bipolar Disorder Patients Receive Antidepressant Drugs In First-Line Treatment
Decision Resources, one of the world's leading research and advisory
firms focusing on pharmaceutical and healthcare issues, finds that 52.3
percent of newly diagnosed bipolar disorder patients are prescribed
antidepressant drugs first line.
The new report entitled Treatment Algorithms in Bipolar Disorder finds
that this high preponderance of early-line antidepressant use stems from
primary care physician prescribing. Surveyed primary care physicians specify
selective serotonin reuptake inhibitors (SSRIs)-including Forest
Laboratories' Lexapro-as a favored first-line treatment choice for patients
with bipolar disorder I with acute depression (51 percent of physicians),
bipolar disorder II with acute depression without hypomania (52 percent of
physicians) and bipolar disorder II with acute depression with hypomania (46
percent of physicians).
"The number of primary care physicians who are diagnosing and treating
bipolar patients has been on the rise in the past few years, but they follow
a different treatment pattern than surveyed psychiatrists," said Madhuri
Borde, Ph.D., analyst at Decision Resources. "Nearly half of the patients
taking SSRIs first line receive these drugs as a monotherapy, despite
guideline recommendations to give bipolar patients presenting with depression
an antimanic first line."
The report also finds that GlaxoSmithKline's Lamictal is the leading
single-agent in first-, second- and third-line therapy amassing 18 percent,
13.8 percent and 16.3 percent patient share in each line of therapy,
respectively. Lamictal's patient share in early lines of therapy is driven by
psychiatrists' belief that this therapy is effective for patients with
bipolar depression.
About Decision Resources
Decision Resources is a world leader in
market research publications, advisory services and consulting designed to
help clients shape strategy, allocate resources and master their chosen
markets. Decision Resources is a Decision Resources, Inc. company.
Decision Resources
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers
best-in-class, high-value information and insights on important sectors of
the healthcare industry. Clients rely on this analysis and data to make
informed decisions.
Decision Resources, Inc.
View drug information on Lamictal.
52 la sutã din nou diagnosticate tulburarea bipolarã Pacienþii Primire antidepresiv droguri în prima linie de tratament - 52 Percent Of Newly Diagnosed Bipolar Disorder Patients Receive Antidepressant Drugs In First-Line Treatment - articole medicale engleza - startsanatate